Tumor pkcδ instigates immune exclusion in egfr-mutated non-small cell lung cancer

HIGHLIGHTS

• who: Yi-Han Zuo from the Key Laboratory of Quality Research in Chinese Medicine, Macau University of Science and Technology, Macau, China have published the research work: Tumor PKCu03b4 instigates immune exclusion in EGFR-mutated non-small cell lung cancer, in the Journal: (JOURNAL)
• what: The ex vivo and in vivo studies were carried out to evaluate the effect. The analysis showed that these significant proteins are highly connected in the same signaling network (Fig 3C). The study provides insight into overcoming the lack of effective strategies to enhance the clinical efficacy of ICB therapy . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.